Barclays’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $96 | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $129K | Sell |
|
|||||
|
2024
Q4 | $186K | Buy |
|
|||||
|
2024
Q3 | $252K | Buy |
|
|||||
|
2024
Q2 | $109K | Sell |
|
|||||
|
2024
Q1 | $754K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $18K | Sell |
|
|||||
|
2021
Q4 | $185K | Buy |
|
|||||
|
2021
Q3 | $107K | Sell |
|
|||||
|
2021
Q2 | $207K | Sell |
|
|||||
|
2021
Q1 | $1.77M | Sell |
|
|||||
|
2020
Q4 | $3.19M | Sell |
|
|||||
|
2020
Q3 | $4.08M | Buy |
|
|||||
|
2020
Q2 | $5.91M | Buy |
|
|||||
|
2020
Q1 | $2.63M | Sell |
|
|||||
|
2019
Q4 | $5.34M | Buy |
|
|||||
|
2019
Q3 | $246K | Sell |
|
|||||
|
2019
Q2 | $711K | Buy |
|
|||||
|
2019
Q1 | $258K | Buy |
|
|||||
|
2018
Q4 | $56K | Sell |
|
|||||
|
2018
Q3 | $418K | Buy |
|
|||||
|
2018
Q2 | $117K | Sell |
|
|||||
|
2018
Q1 | $556K | Buy |
|
|||||
|
2017
Q4 | $120K | Buy |
|
|||||
|
2017
Q3 | $16K | Sell |
|
|||||
|
2017
Q2 | $285K | Buy |
|
|||||
|
2017
Q1 | $35K | Buy |
|
|||||
|
2016
Q4 | $28K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1K | Buy |
|
|||||
|
2016
Q1 | $1K | Sell |
|
|||||
|
2015
Q4 | $2K | Sell |
|
|||||
|
2015
Q3 | $60K | Sell |
|
|||||
|
2015
Q2 | $126K | Sell |
|
|||||
|
2015
Q1 | $781K | Buy |
|
|||||
|
2014
Q4 | $26K | Buy |
|